Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates

A fibrinogen concentrate Haemocomplettan®(Riastap®) or a Factor XIII concentrate Fibrogammin®combined with a mini dose of tranexamic acid can reverse the fibrin instability to fibrinolysis induced by thrombin- or FXa-inhibitor

(2013) Shu He et al.   BRITISH JOURNAL OF HAEMATOLOGY

Treatment of refractory hemorrhage with factor XIII in a patient with hemophilia A with inhibitor

(2013) Christopher Ng et al.   PEDIATRIC BLOOD & CANCER

The Inhibiting Effect of Factor XIII on Hyperfibrinolysis

(2012) Oliver M. Theusinger   ANESTHESIA AND ANALGESIA

The Influence of Bolus to Infusion Delays on Plasma Tissue Plasminogen Activator Levels

(2012) Curtis Smith et al.   International Journal of Stroke

Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes

(2012) C. ROURKE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Fibrinogen and Hemostasis

(2011) Jerrold H. Levy et al.   ANESTHESIA AND ANALGESIA

Factor XIII and Tranexamic Acid But Not Recombinant Factor VIIa Attenuate Tissue Plasminogen Activator–Induced Hyperfibrinolysis in Human Whole Blood

(2011) Daniel Dirkmann et al.   ANESTHESIA AND ANALGESIA

Management of major trauma haemorrhage: treatment priorities and controversies

(2011) Ross Davenport et al.   BRITISH JOURNAL OF HAEMATOLOGY

Recent massive blood transfusion practice in England and Wales: view from a trauma registry

(2011) Gordon Fuller et al.   EMERGENCY MEDICINE JOURNAL

Tranexamic Acid for Trauma Patients: A Critical Review of the Literature

(2011) Andrew P. Cap et al.   JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE

Role of fibrinogen in trauma-induced coagulopathy

(2010) D Fries et al.   BRITISH JOURNAL OF ANAESTHESIA

Standardization of Thromboelastography: Values and Challenges

(2010) Meera Chitlur et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis

(2010) Margareta Blombäck et al.   THROMBOSIS AND HAEMOSTASIS

In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM®)

(2010) Lars Asmis et al.   THROMBOSIS AND HAEMOSTASIS

Prophylactic therapy with Fibrogammin®P is associated with a decreased incidence of bleeding episodes: a retrospective study

(2009) J. LUSHER et al.   HAEMOPHILIA

Evidence that α2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation

(2008) M. W. MOSESSON et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS